HYPERVARIABLE EPITOPE CONSTRUCTS AS A MEANS OF ACCOUNTING FOR EPITOPE VARIABILITY

被引:20
作者
ANDERSON, DE
MALLEY, A
BENJAMINI, E
GARDNER, MB
TORRES, JV
机构
[1] UNIV CALIF DAVIS,SCH MED,DEPT MICROBIOL & IMMUNOL,DAVIS,CA 95616
[2] UNIV CALIF DAVIS,SCH MED,DEPT PATHOL,DAVIS,CA 95616
[3] OREGON REG PRIMATE RES CTR,BEAVERTON,OR 97006
关键词
HYPERVARIABLE EPITOPE CONSTRUCTS; EPITOPE VARIABILITY; SIMIAN IMMUNODEFICIENCY VIRUS;
D O I
10.1016/0264-410X(94)90225-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Epitope variability is one of the greatest obstacles to development of synthetic peptide vaccines. Based on a recently described hypervariable epitope (aa 414-434) on the envelope glycoprotein (gp130) to simian immunodeficiency virus (SIVmac142), we have developed a novel approach to account for epitope variability. We have prepared, in a single synthesis, a cocktail of peptides, designated a hypervariable epitope construct (HEC), which collectively represent all the in vivo variability seen in an epitope. The HEC represents permutations of amino acid substitutions found in the epitope and has been able to induce antibodies with enhanced binding to native SIV and broad immunoreactivity to related epitope analogues.
引用
收藏
页码:736 / 740
页数:5
相关论文
共 22 条
[11]   IDENTIFICATION OF OVERLAPPING HLA CLASS I-RESTRICTED CYTOTOXIC T-CELL EPITOPES IN A CONSERVED REGION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN - DEFINITION OF MINIMUM EPITOPES AND ANALYSIS OF THE EFFECTS OF SEQUENCE VARIATION [J].
JOHNSON, RP ;
TROCHA, A ;
BUCHANAN, TM ;
WALKER, BD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (04) :961-971
[12]   IDENTIFICATION OF 2 NEUTRALIZING AND 8 NONNEUTRALIZING EPITOPES ON SIMIAN IMMUNODEFICIENCY VIRUS ENVELOPE USING MONOCLONAL-ANTIBODIES [J].
KENT, KA ;
RUD, E ;
CORCORAN, T ;
POWELL, C ;
THIRIART, C ;
COLLIGNON, C ;
STOTT, EJ .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (06) :1147-1151
[13]   STRAIN-SPECIFIC NEUTRALIZING DETERMINANT IN THE TRANSMEMBRANE PROTEIN OF SIMIAN IMMUNODEFICIENCY VIRUS [J].
KODAMA, T ;
BURNS, DPW ;
SILVA, DP ;
VERONESE, FD ;
DESROSIERS, RC .
JOURNAL OF VIROLOGY, 1991, 65 (04) :2010-2018
[14]   IDENTIFICATION OF BROADLY REACTIVE CONTINUOUS ANTIGENIC DETERMINANTS OF SIMIAN IMMUNODEFICIENCY VIRUS GLYCOPROTEINS [J].
MILLER, MA ;
MURPHEYCORB, M ;
MONTELARO, RC .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (06) :1153-1164
[15]  
NARDELLI B, 1992, J IMMUNOL, V148, P914
[16]   DESIGN OF A COMPLETE SYNTHETIC PEPTIDE-BASED AIDS VACCINE WITH A BUILT-IN ADJUVANT [J].
NARDELLI, B ;
DEFOORT, JP ;
HUANG, WL ;
TAM, JP .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (08) :1405-1407
[17]   IDENTIFICATION OF ANTIGENIC SITES MEDIATING ANTIBODY-DEPENDENT ENHANCEMENT OF FELINE INFECTIOUS PERITONITIS VIRUS INFECTIVITY [J].
OLSEN, CW ;
CORAPI, WV ;
JACOBSON, RH ;
SIMKINS, RA ;
SAIF, LJ ;
SCOTT, FW .
JOURNAL OF GENERAL VIROLOGY, 1993, 74 :745-749
[18]   VARIATION IN SIMIAN IMMUNODEFICIENCY VIRUS ENV IS CONFINED TO V1 AND V4 DURING PROGRESSION TO SIMIAN AIDS [J].
OVERBAUGH, J ;
RUDENSEY, LM ;
PAPENHAUSEN, MD ;
BENVENISTE, RE ;
MORTON, WR .
JOURNAL OF VIROLOGY, 1991, 65 (12) :7025-7031
[19]  
POSNETT DN, 1988, J BIOL CHEM, V263, P1719
[20]   AN EPITOPE ON THE SURFACE ENVELOPE GLYCOPROTEIN (GP130) OF SIMIAN IMMUNODEFICIENCY VIRUS (SIV(MAC)) INVOLVED IN VIRAL NEUTRALIZATION AND T-CELL ACTIVATION [J].
TORRES, JV ;
MALLEY, A ;
BANAPOUR, B ;
ANDERSON, DE ;
AXTHELM, MK ;
GARDNER, MB ;
BENJAMINI, E .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (05) :423-430